News | News By Subject | News by Disease News By Date | Search News

Glioblastoma/Glioma News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Glioblastoma Treatment Market Will Expand to $3.3 Billion by 2024, GlobalData Report Says     1/14/2016
Agenus (AGEN) Acquires PhosImmune in $44.9 Million Deal     12/29/2015
Celldex (CLDX) Cancer Vaccine Extends Life for Those With Brain Cancer     11/24/2015
Celsion (CLSN) Updates Clinical Trial Data and Slashes 20% of Workforce     9/9/2015
NW Bio (NWBO) Temporarily Halts Patient Screening for DCVax-L Brain Cancer Study     8/24/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
EXCLUSIVE: Experimental Cancer Drug From Oncoceutics Could Be Fast-Tracked, Says Exec     3/6/2015
EXCLUSIVE: Science "Finally Catching Up" With GBM Tumors, Says DelMar Pharmaceuticals CEO     2/27/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
AbbVie (ABBV) Touts Early Phase 1 Success With Brain Cancer Drug     6/2/2014
AngioChem's ANG1005 Received Fast Track And Orphan Drug Designation From FDA For The Treatment Of Glioblastoma Multiforme     5/30/2014
ImmunoCellular Therapeutics, Ltd (IMUC) Killed As Brain Cancer Drug Fails Key Phase 2 Study; Stock Down -59.56% At 10:12AM ET On Thursday     12/13/2013
EMD Serono Reports Disappointing Results for Cancer Drug Test     2/25/2013
Roche (RHHBY)'s Avastin Shows Mixed Results in Glioblastoma     11/23/2012

News from Around the Web
New Approach To Gene Therapy May Shrink Brain Tumors, Prevent Their Spread, Massachusetts General Hospital Neuroscience Center Study     9/26/2008
Brain Cancer Vaccine's Immune Response Key to Outcomes, Cedars-Sinai Study     7/16/2008
University of Alabama at Birmingham-Developed Glioma Drug Shows Promise in Phase 1 Trial     11/12/2007
Mayo Clinic Tests Novel Vaccine to Treat Aggressive Brain Tumors     10/24/2007
Genentech, Inc. (DNA)'s Avastin Seen As Helpful Against Deadly Brain Tumor     10/19/2007
University of California, San Francisco (UCSF) Brain Tumor Vaccine Trial Shows Promising Results     4/16/2007
Starve Brain Tumors Of Blood Shows Positive Results     1/22/2007
Cancer Immunoresistance Linked To Loss Of Tumor Suppressor Gene     12/11/2006
Brain Cancer Vaccine Made From Patients' Tumours     11/17/2006
Alkermes (ALKS) More Than A Drug Delivery Company     7/17/2006
Ark To File For Exceptional Approval Of Cerepro Gene Therapy     1/17/2005
Ark Therapeutics Raises £55M, Ends IPO Drought In London     3/10/2004

Press Releases
ImmunoCellular Therapeutics, Ltd (IMUC) Reports Updated Immune Monitoring Data From ICT-107 Phase 2 Trial In Newly Diagnosed Glioblastoma At The Society For Neuro-Oncology Annual Meeting 2016     11/21/2016
Cortice Biosciences Announces Presentation Of Results From A Phase I/II Clinical Trial Evaluating TPI 287 For Treatment Of Recurrent Glioblastoma At The 21st Annual Scientific Meeting Of The Society Of Neuro-Oncology     11/21/2016
Agios (AGIO) Announces Phase I Data From Dose Expansion Cohorts Of AG-120 In Patients With IDH1 Mutant Positive Glioma And Chondrosarcoma     11/21/2016
DNAtrix, Inc. Announces First Patients Treated In Phase 2 Trial With DNX-2401 And KEYTRUDA     11/2/2016
Genentech (RHHBY) Offloads Brain Drug to Tiny Australian Biotech Novogen (NVGN) for Bargain Price     10/31/2016
Novogen Limited (NVGN) Acquires Privately-Held Neuro-Oncology Company To Support Development Of GDC-0084 In Glioblastoma     10/31/2016
Cannabics Pharma Discovers Specific Ratios Of THC/CBD Effectuate Reduction In U87MG Glioblastoma Cell Viability     10/24/2016
Cannabics Pharma Discovers Specific Ratios Of THC/CBD Effectuate Reduction In U87MG Glioblastoma Cell Viability     10/20/2016
First Patient Dosed In CANBridge Life Sciences’s CAN-008 Phase I/II Trial In Newly-Diagnosed Glioblastoma Multiforme In Taiwan     9/26/2016
Diffusion Pharma Successfully Completes Animal Toxicity Studies In Preparation For Phase III Pivotal Trial Of TSC In New Diagnosed Glioblastoma Patients     9/19/2016
Kansas University Medical Center And Baylor Scott & White Research Institute Become The Latest Investigation Sites For Nativis, Inc. Recurrent Glioblastoma (Rgbm) Clinical Trial     9/7/2016
Oncotelic And Autotelic Announce Clinical Data Supporting IL-8 Spike As A Prognostic Biomarker For Immunotherapy     9/2/2016
Kadmon Initiates Phase II Clinical Trial Evaluating Tesevatinib In Glioblastoma     8/29/2016
DNAtrix, Inc. Receives EMA PRIME Designation     7/27/2016
CANBridge Life Sciences’s CAN-008 Approved For Phase I/II Trial In Newly-Diagnosed Glioblastoma Multiforme In Taiwan     7/26/2016

//-->